Teaching Video NeuroImage: Amaurosis Fugax Due to Recurrent Central Retinal Artery Occlusion by Microemboli
Citation Manager Formats
Make Comment
See Comments

A previously healthy 71-year-old woman with hypercholesterolemia and current tobacco use presented with transient painless vision loss in the left eye without other neurologic abnormalities. The 30-second episodes, followed by a recovery, repeated in 2- to 3-minute intervals.1 Microemboli passing through central retinal artery (CRA) vasculature (Video 1) originated from a complicated atherosclerotic plaque in the left internal carotid artery (Figure). After receiving intravenous thrombolysis 5 hours after symptom onset,2 she reported a scotoma in the inferior part of her left eye, which persisted 2 years later. Retinal embolism from carotid artery disease is the most common cause of CRA occlusion.
Nonstenotic, mixed (predominantly soft) atherosclerotic plaque (arrows) in the proximal left internal carotid artery with thin calcifications on CT angiography sagittal (A) and axial (B) slices. Reconstructed fundus image (C) showing microemboli (encircled yellow arrow). Perimetry at 3-month follow-up corresponding to the reported scotoma (D).
Video 1
Microemboli passing through the superior temporal branch of the central retinal artery. The video was acquired from an ocular slitlamp using hand-held cell phone camera with 20 frames per second (fps) sampling. Motion artifacts were suppressed with nonlinear image registration using Elastix libraries. The resampled 40-fps video was exported twice as slow.Download Supplementary Video 1 via http://dx.doi.org/10.1212/200890_Video_1
Study Funding
No targeted funding reported.
Disclosure
The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Whitley Aamodt, MD, MPH.
Teaching slides links.lww.com/WNL/C147
- Received January 17, 2022.
- Accepted in final form May 11, 2022.
- © 2022 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.